BBIO logo

BBIO
BridgeBio Pharma Inc

5,360
Mkt Cap
$15.49B
Volume
1.84M
52W High
$81.33
52W Low
$28.33
PE Ratio
-18.60
BBIO Fundamentals
Price
$77.49
Prev Close
$77.87
Open
$78.35
50D MA
$73.91
Beta
1.31
Avg. Volume
1.79M
EPS (Annual)
-$2.88
P/B
-7.76
Rev/Employee
$303,975.34
Loading...
Loading...
News
all
press releases
Emerald Mutual Fund Advisers Trust Lowers Stock Position in BridgeBio Pharma, Inc. $BBIO
Emerald Mutual Fund Advisers Trust trimmed its stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 36.3% during the third quarter, according to its most recent 13F filing with the SEC. The...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
BridgeBio Pharma (NASDAQ:BBIO) Reaches New 52-Week High - Still a Buy?
BridgeBio Pharma (NASDAQ:BBIO) Sets New 52-Week High - Still a Buy...
MarketBeat·6d ago
News Placeholder
BridgeBio Pharma, Inc. $BBIO Shares Sold by Emerald Advisers LLC
Emerald Advisers LLC lessened its stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 29.5% in the 3rd quarter, according to the company in its most recent filing with the Securities...
MarketBeat·7d ago
News Placeholder
Wells Fargo & Company Raises BridgeBio Pharma (NASDAQ:BBIO) Price Target to $88.00
Wells Fargo & Company upped their target price on shares of BridgeBio Pharma from $84.00 to $88.00 and gave the company an "overweight" rating in a research report on Tuesday...
MarketBeat·8d ago
News Placeholder
Mizuho Markets Americas LLC Has $7.29 Million Holdings in BridgeBio Pharma, Inc. $BBIO
Mizuho Markets Americas LLC boosted its stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 46.1% in the third quarter, according to its most recent disclosure with the Securities and...
MarketBeat·9d ago
News Placeholder
Pharmaceutical Stocks To Keep An Eye On - January 16th
Eli Lilly and Company, Novo Nordisk A/S, AbbVie, Pfizer, Abbott Laboratories, AstraZeneca, and BridgeBio Pharma are the seven Pharmaceutical stocks to watch today, according to MarketBeat's stock...
MarketBeat·12d ago
News Placeholder
BridgeBio Pharma (NASDAQ:BBIO) Sees Large Volume Increase - Still a Buy?
BridgeBio Pharma (NASDAQ:BBIO) Sees Unusually-High Trading Volume - Here's Why...
MarketBeat·12d ago
News Placeholder
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Consensus Recommendation of "Moderate Buy" by Analysts
Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) have received an average recommendation of "Moderate Buy" from the twenty-three research firms that are presently covering the stock...
MarketBeat·13d ago
News Placeholder
BridgeBio Pharma Prices $550 Mln Of 0.75% Convertible Senior Notes Due 2033
(RTTNews) - BridgeBio Pharma Inc. (BBIO) announced the pricing of $550 million aggregate principal amount of 0.75% convertible senior notes due 2033 in a private offering. In connection with the...
Nasdaq News: Markets·13d ago
News Placeholder
BridgeBio Pharma (NASDAQ:BBIO) Shares Gap Down - Here's What Happened
BridgeBio Pharma (NASDAQ:BBIO) Shares Gap Down - Here's Why...
MarketBeat·13d ago
<
1
2
...
>

Latest BBIO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.